Results 11 to 20 of about 11,991 (261)

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

open access: yesHepatology, EarlyView., 2022
Hepatic endothelial Alk1 signaling protects from development of vascular malformations while maintaining organ‐specific endothelial differentiation and angiocrine portmanteau of the names Wingless and Int‐1 signaling. Abstract Background and Aims In hereditary hemorrhagic telangiectasia (HHT), severe liver vascular malformations are associated with ...
Christian David Schmid   +20 more
wiley   +1 more source

Purinergic receptors in the splanchnic circulation [PDF]

open access: yesPurinergic Signalling, 2008
There is considerable evidence that purines are vasoactive molecules involved in the regulation of blood flow. Adenosine is a well known vasodilator that also acts as a modulator of the response to other vasoactive substances. Adenosine exerts its effects by interacting with adenosine receptors.
Morato, Manuela   +2 more
openaire   +2 more sources

Pathophysiology, diagnosis and treatment of ascites in cirrhosis

open access: yesAnnals of Hepatology, 2002
The mechanism by which ascites develops in cirrhosis is multifactorial Severe sinusoidal portal hypertension and hepatic insufficiency are the initial factors.
Vicente Arroyo, M.D.
doaj   +1 more source

Descending Aorta Blood Flow Characteristics before the Development of Necrotizing Enterocolitis in Preterm Neonates [PDF]

open access: yesNeonatal Medicine, 2018
Purpose To investigate the hemodynamic risk factors for necrotizing enterocolitis (NEC), we analyzed the characteristics of descending aorta (DA) blood flow in preterm neonates, who later developed NEC.
Kyung Min Kim   +9 more
doaj   +1 more source

Superior Mesenteric Venous Thrombosis Presenting with Hematemesis: A Case Report

open access: yesThe Annals of African Surgery, 2023
The superior mesenteric vein (SMV) is one of the two tributaries to the portal vein, which is the main pre-hepatic drainage channel of the splanchnic circulation.
Edward Mackutwa   +3 more
doaj   +1 more source

The Lymphatic Headmaster of the Mast Cell-Related Splanchnic Inflammation in Portal Hypertension

open access: yesCells, 2019
Portal hypertension is a common complication of liver disease, either acute or chronic. Consequently, in chronic liver disease, such as the hypertensive mesenteric venous pathology, the coexisting inflammatory response is classically characterized by the
Maria-Angeles Aller   +4 more
doaj   +1 more source

Effect of intraabdominal hypertension on splanchnic blood flow in children with appendicular peritonitis

open access: yesJournal of Anaesthesiology Clinical Pharmacology, 2021
Background and Aims: Intraabdominal hypertension (IAH) is poorly diagnosed condition that cause splanchnic hypoperfusion and abdominal organs ischemia and can lead to multiple organ failure. There are no scientific data regarding effect of intraabdominal
Valentyna M Perova-Sharonova   +3 more
doaj   +1 more source

Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms [PDF]

open access: yesJournal of Tehran University Heart Center, 2007
Cirrhosis is characterized by marked abnormalities in the cardiovascular system. A hyperdynamic splanchnic and systemic circulation is typical of cirrhotic patients and has been observed in all experimental forms of portal hypertension.
Ahmad Reza Dehpour   +2 more
doaj   +2 more sources

Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans

open access: yesMolecular Metabolism, 2015
Background & aims: Fibroblast growth factor 21 (FGF-21) is a liver-derived metabolic regulator induced by energy deprivation. However, its regulation in humans is incompletely understood.
Jakob Schiøler Hansen   +7 more
doaj   +1 more source

Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Hepatorenal Syndrome (HRS) is a potentially fatal complication of hepatic failure and portal hypertension. Among the various treatments available including octreotide, midodrine and albumin, the current standard of care for stable patients is ...
Aneesh Basheer   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy